Khairy: Malaysia, Merck sign agreement for Covid-19 drug ...

The Star Online - 07 Oct 2021
PUTRAJAYA: Malaysia has signed an agreement with Merck Sharp & Dohme (MSD) to procure antiviral medicine Molnupiravir for Covid-19 treatment.

Molnupiravir influences SARS-CoV-2 evolution in immunocompromised patients

News-Medical.Net - 25 Mar 2024
Molnupiravir influences SARS-CoV-2 evolution in immunocompromised patients ...

Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients

Nature.com - 23 Feb 2024
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients ...

Covid-19: Merck's antiviral pill molnupiravir may have led to virus mutations, says study

New Straits Times - 25 Sep 2023
Covid-19: Merck's antiviral pill molnupiravir may have led to virus mutations, says study ...

COVID-19 antiviral treatment should be taken for longer, says study

Medical Xpress - 27 Feb 2024
COVID-19 antiviral treatment should be taken for longer, says study ...

Trial Shows Increased SARS-CoV-2 Mutations, Delayed Viral Clearance With Molnupiravir Treatment

IDSA - 29 Mar 2024
Trial Shows Increased SARS-CoV-2 Mutations, Delayed Viral Clearance With Molnupiravir Treatment ...

Use of antiviral may be fuelling evolution of Covid, scientists say

The Guardian - 25 Sep 2023
Use of antiviral may be fuelling evolution of Covid, scientists say ...

Molnupiravir linked to COVID mutations

RACGP - 27 Sep 2023
Molnupiravir linked to COVID mutations ...

New data show Paxlovid outperforms molnupiravir against severe COVID-19 outcomes

University of Minnesota Twin Cities - 22 Mar 2024
New data show Paxlovid outperforms molnupiravir against severe COVID-19 outcomes ...

SARS-CoV-2 Mutation Signature Linked to Antiviral Molnupiravir

Genetic Engineering & Biotechnology News - 26 Sep 2023
SARS-CoV-2 Mutation Signature Linked to Antiviral Molnupiravir ...

A validated LC-MS/MS method for determination of Molnupiravir and Favipiravir in human plasma; Assessment of the ...

ScienceDirect.com - 16 Dec 2023
A validated LC-MS/MS method for determination of Molnupiravir and Favipiravir in human plasma; Assessment of the ... ...

Molnupiravir: COVID drug linked to virus mutations, scientists say

Sky News - 25 Sep 2023
Molnupiravir: COVID drug linked to virus mutations, scientists say ...

A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes

Nature.com - 25 Sep 2023
A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes ...

Medication and mutations: molnupiravir's impact on SARS-CoV-2 genomes

News-Medical.Net - 27 Sep 2023
Medication and mutations: molnupiravir's impact on SARS-CoV-2 genomes ...

Both Paxlovid, molnupiravir lower COVID Omicron deaths, hospitalizations, studies conclude

University of Minnesota Twin Cities - 21 Sep 2023
Both Paxlovid, molnupiravir lower COVID Omicron deaths, hospitalizations, studies conclude ...

A newly developed and validated environmentally friendly RP-HPLC stability indicating method for the COVID-19 ...

ScienceDirect.com - 14 Jan 2024
A newly developed and validated environmentally friendly RP-HPLC stability indicating method for the COVID-19 ... ...

Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19: a ...

Nature.com - 09 Feb 2024
Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19: a ... ...

Oral antivirals Molnupiravir and Nirmatrelvir-Ritonavir lower COVID-19 risks in type 2 diabetes patients

News-Medical.Net - 24 May 2023
Oral antivirals Molnupiravir and Nirmatrelvir-Ritonavir lower COVID-19 risks in type 2 diabetes patients ...

White targeted chromatographic screening method of Molnupiravir and its metabolite with degradation kinetics ...

Nature.com - 20 Oct 2023
White targeted chromatographic screening method of Molnupiravir and its metabolite with degradation kinetics ... ...

Transporter modulation of molnupiravir and its metabolite β-D-N4-hydroxycytidine across the blood-brain barrier in a ...

Nature.com - 19 Oct 2023
Transporter modulation of molnupiravir and its metabolite β-D-N4-hydroxycytidine across the blood-brain barrier in a ... ...

Molnupiravir